Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 5/2002

01-07-2002 | Original Article

Outcome and cost implications of cardiopulmonary resuscitation in the medical intensive care unit of a comprehensive cancer center

Authors: Susannah Wallace, Michael S. Ewer, Kristen J. Price, Thomas W. Feeley

Published in: Supportive Care in Cancer | Issue 5/2002

Login to get access
Metadata
Title
Outcome and cost implications of cardiopulmonary resuscitation in the medical intensive care unit of a comprehensive cancer center
Authors
Susannah Wallace
Michael S. Ewer
Kristen J. Price
Thomas W. Feeley
Publication date
01-07-2002
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 5/2002
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-002-0353-4

Other articles of this Issue 5/2002

Supportive Care in Cancer 5/2002 Go to the issue

Special Article

Symptoms and prognosis in advanced cancer

Original Article

What do patients living with advanced cancer and their carers want to know? – A needs assessment

Original Article

Isometric strength measurement for muscle weakness in cancer patients

Original Article

How common are thoughts of self-harm in a UK palliative care population?

Review Article

Fatigue associated with cancer and its treatment

Original article

The effects of information and negative affect on severity of side effects from radiation therapy for prostate cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits